STAXYN

This brand name is authorized in Canada, United States

Active ingredients

The drug STAXYN contains one active pharmaceutical ingredient (API):

1 Vardenafil UNII 5M8S2CU0TS - VARDENAFIL HYDROCHLORIDE

Vardenafil is a potent and selective inhibitor of the cGMP specific phosphodiesterase type 5 (PDE5), the most prominent PDE in the human corpus cavernosum. Vardenafil is an oral therapy for the improvement of erectile function in men with erectile dysfunction. In the natural setting, i.e. with sexual stimulation it restores impaired erectile function by increasing blood flow to the penis. Read about Vardenafil

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
STAXYN Tablet, orally disintegrating	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G04BE09	Vardenafil	G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BE Drugs used in erectile dysfunction
Discover more medicines within G04BE09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02372436
Country: US	FDA, National Drug Code	Identifier(s): 0173-0822